VARICELLA

(CHICKENPOX-VARIVAX) VACCINE

VACCINE USAGE: VARIVAX is a vaccine indicated for active immunization for the prevention of varicella in individuals 12 months of age and older.

VACCINE DOSAGE: each dose is approximately 0.5 mL after reconstitution and is administered by subcutaneous injection.

CHILDREN (12 MONTHS TO 12 YEARS OF AGE):

  • If a second dose is administered, there should be a minimum interval of 3 months between doses.

ADOLESCENTS (≥13 YEARS OF AGE) AND ADULTS:

  • Two doses, to be administered a minimum of 4 weeks apart.

 

VACCINE INGEDIENTS: sucrose, phosphate, glutamate, gelatin. Monosodium L-glutamate, sodium phosphate dibasic, potassium phosphate monobasic, EDTA, residual components of MRC-5 cells including DNA and protein, neomycin, fetal bovine serum, human diploid cell cultures.

LIVE VIRUS VACCINE THAT HAS THE POTENTIAL TO SHED

ADVERSE VACCINE REACTIONS: fever, varicella-like rash, anaphylaxis (including anaphylactic shock), pneumonia, facial edema, necrotizing, retinitis, aplastic anemia, thrombocytopenia, varicella (vaccine strain), encephalitis, Guillain-Barre syndrome, Bell’s palsy, non- febrile seizures, aseptic meningitis, dizziness, paresthesia.